Enliven Therapeutics to Present at Two Upcoming Investor Conferences
May 29 2024 - 4:05PM
Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a
clinical-stage precision oncology company focused on the discovery
and development of next-generation small molecule kinase
inhibitors, today announced that management will present at the
following investor conferences in June:
Jefferies Global Healthcare ConferenceFormat:
Fireside ChatDate: Wednesday, June 5Time: 8:30 a.m. ET
Goldman Sachs Annual Global Healthcare
ConferenceFormat: Fireside ChatDate: Monday, June 10Time:
3:20 p.m. ET
Both fireside chats will be webcast live and can be accessed by
visiting the investor relations section of the Company’s website at
https://ir.enliventherapeutics.com/. Each webcast will be archived
for a period of 30 days following the conclusion of the live
event.
About Enliven TherapeuticsEnliven Therapeutics
is a clinical-stage biopharmaceutical company focused on the
discovery and development of small molecule inhibitors to help
people with cancer not only live longer, but live better. Enliven
aims to address existing and emerging unmet needs with a precision
oncology approach that improves survival and enhances overall
well-being. Enliven’s discovery process combines deep insights in
clinically validated biological targets and differentiated
chemistry to design potentially first-in-class or best-in-class
therapies. Enliven is based in Boulder, Colorado.
ContactInvestorsir@enliventherapeutics.com
Mediamedia@enliventherapeutics.com
Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
From Jul 2023 to Jul 2024